Total medical devices industry cross border M&A deals worth $4.64bn were announced globally in Q1 2021, led by Boston Scientific’s $1.07bn asset transaction with Lumenis, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 2.4% over the previous quarter of $4.53bn and a drop of 23.2% when compared with the last four-quarter average, which stood at $6.04bn.

Comparing cross border M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $2.37bn. At the country level, the Belgium topped the list in terms of deal value at $1.15bn.

In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of cross border M&A deals activity in Q1 2021 was the US with 17 deals, followed by Canada with seven and Germany with seven.

In 2021, at the end of , cross border M&A deals worth $4.64bn were announced globally in medical devices industry, marking a decrease of 720.3% year on year.

Cross Border M&A deals in medical devices industry in Q1 2021: Top deals

The top five cross border M&A deals in medical devices industry accounted for 77.3% of the overall value during Q1 2021.

The combined value of the top deals stood at $3.59bn, against the overall value of $4.64bn recorded for the quarter.

The top five medical devices industry cross border medical devices deals of Q1 2021 tracked by GlobalData were:

1) Boston Scientific’s $1.07bn asset transaction with Lumenis

2) The $880.85m asset transaction with Novasep Holding by Thermo Fisher Scientific

3) Koninklijke Philips’ $635m acquisition of Capsule Technologies

4) The $591m acquisition of Oxford Immunotec by PerkinElmer

5) Savaria’s acquisition of Handicare Group for $409.7m.